All Q2 FY27 results →
FB

Five-Star Bus.Fi

Q2 FY27Finance

Five-Star Business Finance Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and fundraising.

Price₹448
Market cap₹13.2K Cr
P/E12.0
Updated26 Oct 2026
Read3 min read

Five-Star Bus.Fi Q2 FY27 key numbers

Revenue
Total Income for Q2FY27: ₹8,750 Mn, up 8% year-on-year (Y-o-Y) from ₹8,065 Mn in Q2FY26.

As stated in Five-Star Bus.Fi's Q2 FY27 investor presentation · published 26 Oct 2026. Reported figures, not investment advice.

Based on Five-Star Bus.Fi's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Total Income for Q2FY27: ₹8,750 Mn, up 8% year-on-year (Y-o-Y) from ₹8,065 Mn in Q2FY26 - Loan Portfolio for Q2FY27: ₹146,396 Mn, up 14% Y-o-Y from ₹128,471 Mn in Q2FY26 - Loan Disbursement in Q2F EBITDA (Pre-provision Operating Profit, PPOP) for Q2FY27: ₹4,390 Mn; Y-o-Y change: +1% - Operating margin is not explicitly stated as a percentage, but operating expenses to average loan portfolio is 7.56% (Q2FY27) versus 6.12% (Q2FY26), indicating higher operating expenses relative to portfolio.

From Five-Star Bus.Fi's Q2 FY27 earnings-call transcript · updated 26 Oct 2026.

Revenue & Sales Performance

  • Total Income for Q2FY27: ₹8,750 Mn, up 8% year-on-year (Y-o-Y) from ₹8,065 Mn in Q2FY26
  • Loan Portfolio for Q2FY27: ₹146,396 Mn, up 14% Y-o-Y from ₹128,471 Mn in Q2FY26
  • Loan Disbursement in Q2FY27: ₹20,778 Mn, up 39% Y-o-Y from ₹14,964 Mn (FY26 figure for comparison)

2 more points from Five-Star Bus.Fi's call on revenue

Create a free account to keep reading this call

Profitability & Margins

  • EBITDA (Pre-provision Operating Profit, PPOP) for Q2FY27: ₹4,390 Mn; Y-o-Y change: +1%
  • Operating margin is not explicitly stated as a percentage, but operating expenses to average loan portfolio is 7.56% (Q2FY27) versus 6.12% (Q2FY26), indicating higher operating expenses relative to portfolio. Operating cost to income ratio rose to 38.04% (Q2FY27) from 31.05% (Q2FY26).
  • Profit After Tax (PAT) for Q2FY27: ₹2,993 Mn; Y-o-Y change: +5%
  • No explicit EBITDA or operating margin outlook is stated in the presentation. Financial highlights show steady improvements in net interest income and profit after tax but no forward margin guidance is provided.

Fundraising & Capital Structure

  • Page 33 details incremental borrowings of ₹8,250 Mn in FY26 and ₹20,778 Mn in Q2FY27, with cost of incremental borrowings around 8.78% in Q2FY27, showing a reduction over past years.
  • Page 36 shows borrowings other than debt securities slightly increased from ₹73,121 Mn in Q1FY27 to ₹74,011 Mn in Q2FY27; debt securities also rose marginally.
  • Total equity increased from ₹76,534 Mn in Q1FY27 to ₹79,034 Mn in Q2FY27, indicating some equity growth.
  • Page 34 highlights a strong liquidity buffer of ₹24,067 Mn as of Sep 2026, supported by unavailed bank sanctions of ₹11,200 Mn.

2 more points from Five-Star Bus.Fi's call on fundraising

Create a free account to keep reading this call

Top-ranked in Finance

Ranked on what management guided this quarter

Guidance-ranked
1Mufin Green
Rev 1Mar 1
2Akiko
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Others in Finance this season

  • REC Ltd (Q2 FY27)

    Revenue from Operations for the quarter ended 30-09-2026: ₹15,000.40 crores (Consolidated), ₹14,727.69 crores (Standalone). Key results statement takeaways from

  • AAVAS Financiers (Q2 FY27)

    Processing Fee): ₹6,501.9 mn, up 12.6% YoY from ₹5,772.9 mn in Q2 FY26. Key investor presentation takeaways from AAVAS Financiers's Q2 FY27 investor presentatio

  • 3P Land Holdings Ltd (Q2 FY27)

    Quarterly total revenue from operations for 3P Land Holdings Limited (Standalone and Consolidated) for Q2 FY 2026 (ended 30.09.2026) is reported as ₹187 lakh…

  • CRISIL Ltd (Q2 FY27)

    Income from operations for Q3 FY26: ₹1,095 crore, up 20.2% YoY from Q3 FY25 (₹911 crore). Key investor presentation takeaways from CRISIL Ltd's Q2 FY27 investor

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Five-Star Bus.Fi and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Five-Star Bus.Fi Q2 FY27 results?

Total Income for Q2FY27: ₹8,750 Mn, up 8% year-on-year (Y-o-Y) from ₹8,065 Mn in Q2FY26 - Loan Portfolio for Q2FY27: ₹146,396 Mn, up 14% Y-o-Y from ₹128,471 Mn in Q2FY26 - Loan Disbursement in Q2F EBITDA (Pre-provision Operating Profit, PPOP) for Q2FY27: ₹4,390 Mn; Y-o-Y change: +1% - Operating margin is not explicitly stated as a percentage, but operating expenses to average loan portfolio is 7.56% (Q2FY27) versus 6.12% (Q2FY26), indicating higher operating expenses relative to portfolio.

What is Five-Star Bus.Fi share price analysis?

Five-Star Bus.Fi currently shows a neutral. The stock trades at a P/E of 12.0 with a market cap of ₹13,237 Cr. Investors should review the full earnings analysis for detailed insights.

Is Five-Star Bus.Fi planning capital expenditure?

The investor presentation for Five Star Business Finance Limited does not describe any capex, capacity expansion, or new plant/project with specific amounts, status, or timelines.

Keep Five-Star Bus.Fi on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.